Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

Editorial Comment.

Chin JL.

J Urol. 2019 Dec;202(6):1197-1198. doi: 10.1097/01.JU.0000582668.13559.54. Epub 2019 Sep 16. No abstract available.

PMID:
31524572
2.

Patterns of splenic arterial enhancement on computed tomography are related to changes in portal venous pressure.

McCormick PA, Malone DE, Docherty JR, Kiat C, Christopher BT, Chin JL.

Eur J Gastroenterol Hepatol. 2019 Mar;31(3):352-356. doi: 10.1097/MEG.0000000000001286.

PMID:
30334908
3.

Twelve-month prostate volume reduction after MRI-guided transurethral ultrasound ablation of the prostate.

Bonekamp D, Wolf MB, Roethke MC, Pahernik S, Hadaschik BA, Hatiboglu G, Kuru TH, Popeneciu IV, Chin JL, Billia M, Relle J, Hafron J, Nandalur KR, Staruch RM, Burtnyk M, Hohenfellner M, Schlemmer HP.

Eur Radiol. 2019 Jan;29(1):299-308. doi: 10.1007/s00330-018-5584-y. Epub 2018 Jun 25.

PMID:
29943185
4.

Chronic renal pain: An approach to investigation and management.

Dewar MJ, Chin JL.

Can Urol Assoc J. 2018 Jun;12(6 Suppl 3):S167-S170. doi: 10.5489/cuaj.5327. Review. No abstract available.

5.

Are There Extended Benefits with Extended Lymph Node Dissection During Radical Prostatectomy?

Chin JL.

Eur Urol. 2018 Aug;74(2):138-139. doi: 10.1016/j.eururo.2018.03.017. Epub 2018 Apr 18. No abstract available.

PMID:
29678357
6.

What Can Lexical Tone Training Studies in Adults Tell Us about Tone Processing in Children?

Antoniou M, Chin JLL.

Front Psychol. 2018 Jan 23;9:1. doi: 10.3389/fpsyg.2018.00001. eCollection 2018. Review.

7.

Next-generation prostate cancer risk calculator for primary care physicians.

Nam RK, Satkunavisam R, Chin JL, Izawa J, Trachtenberg J, Rendon R, Bell D, Singal R, Sherman C, Sugar L, Chagin K, Kattan MW.

Can Urol Assoc J. 2018 Feb;12(2):E64-E70. doi: 10.5489/cuaj.4696. Epub 2017 Dec 1.

8.

Re: Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy.

Chin JL.

Eur Urol. 2018 May;73(5):808. doi: 10.1016/j.eururo.2017.12.013. Epub 2017 Dec 21. No abstract available.

PMID:
29275832
9.

Diagnosis and Management of Upper Gastrointestinal Neuroendocrine Tumors.

Chin JL, O'Toole D.

Clin Endosc. 2017 Nov;50(6):520-529. doi: 10.5946/ce.2017.181. Epub 2017 Nov 30. Review.

10.

Editorial Comment.

Chin JL, Brock G.

J Urol. 2018 Feb;199(2):471-472. doi: 10.1016/j.juro.2017.08.122. Epub 2017 Dec 15. No abstract available.

PMID:
29080403
11.

Robotic-assisted Radical Prostatectomy for High-risk Cancer: Time for "Sexta-fecta".

Chin JL.

Eur Urol. 2018 Feb;73(2):224-225. doi: 10.1016/j.eururo.2017.05.044. Epub 2017 Jun 3. No abstract available.

PMID:
28583310
12.

Editorial Comment on Tay et al.

Chin JL.

J Endourol. 2017 Jun;31(6):572. doi: 10.1089/end.2017.0290. No abstract available.

PMID:
28462605
13.

Incidental Prostate Adenocarcinoma in Cystoprostatectomy Specimens: Partial Versus Complete Prostate Sampling.

Filter ER, Gabril MY, Gomez JA, Wang PZT, Chin JL, Izawa J, Moussa M.

Int J Surg Pathol. 2017 Aug;25(5):414-420. doi: 10.1177/1066896917696745. Epub 2017 Mar 22.

PMID:
28381150
14.

Assessment of histopathological features of needle biopsy in recurrent prostate cancer following salvage high-intensity focused ultrasound.

Billia M, Siddiqui KM, Chan S, Li F, Al-Zahrani A, Gomez JA, Chin JL.

Can Urol Assoc J. 2016 Nov-Dec;10(11-12):416-422. doi: 10.5489/cuaj.3918.

15.

Should Patients Receiving Antiplatelet Agents Undergo Platelet Transfusion for Acute Gastrointestinal Bleeding?

Chin JL, Chaffay B, O'Toole D.

Clin Gastroenterol Hepatol. 2017 May;15(5):789. doi: 10.1016/j.cgh.2016.12.017. Epub 2016 Dec 23. No abstract available.

PMID:
28025155
16.

Pathological, Oncologic and Functional Outcomes of a Prospective Registry of Salvage High Intensity Focused Ultrasound Ablation for Radiorecurrent Prostate Cancer.

Siddiqui KM, Billia M, Arifin A, Li F, Violette P, Chin JL.

J Urol. 2017 Jan;197(1):97-102. doi: 10.1016/j.juro.2016.06.092. Epub 2016 Jul 13.

PMID:
27422297
17.

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?

Chin JL, Pavlides M, Moolla A, Ryan JD.

Front Pharmacol. 2016 Jun 20;7:159. doi: 10.3389/fphar.2016.00159. eCollection 2016. Review.

18.

Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion.

Gibson E, Bauman GS, Romagnoli C, Cool DW, Bastian-Jordan M, Kassam Z, Gaed M, Moussa M, Gómez JA, Pautler SE, Chin JL, Crukley C, Haider MA, Fenster A, Ward AD.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):188-96. doi: 10.1016/j.ijrobp.2016.04.018. Epub 2016 Apr 21.

PMID:
27375167
19.

Common bile duct duplication: double bile ducts, double trouble.

Chin JL, Sengupta S, Morrin MM, Murray FE, Patchett SE.

Gastrointest Endosc. 2017 Apr;85(4):855-856. doi: 10.1016/j.gie.2016.05.005. Epub 2016 May 11. No abstract available.

PMID:
27179690
20.

Long-Term Oncologic Outcomes of Salvage Cryoablation for Radio-Recurrent Prostate Cancer.

Siddiqui KM, Billia M, Al-Zahrani A, Williams A, Goodman C, Arifin A, Violette P, Bauman G, Chin JL.

J Urol. 2016 Oct;196(4):1105-11. doi: 10.1016/j.juro.2016.04.080. Epub 2016 May 6.

PMID:
27157372
21.

Noninvasive Assessment of Liver Fibrosis and Cirrhosis With Ultrasound-based Elastography in Alcohol-related Liver Disease.

Chin JL, Chan G, Ryan JD.

Gastroenterology. 2016 May;150(5):1251-1252. doi: 10.1053/j.gastro.2015.12.045. Epub 2016 Mar 25. No abstract available.

PMID:
27020334
22.

Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry.

Biggs CN, Siddiqui KM, Al-Zahrani AA, Pardhan S, Brett SI, Guo QQ, Yang J, Wolf P, Power NE, Durfee PN, MacMillan CD, Townson JL, Brinker JC, Fleshner NE, Izawa JI, Chambers AF, Chin JL, Leong HS.

Oncotarget. 2016 Feb 23;7(8):8839-49. doi: 10.18632/oncotarget.6983.

23.

Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.

Chin JL, Billia M, Relle J, Roethke MC, Popeneciu IV, Kuru TH, Hatiboglu G, Mueller-Wolf MB, Motsch J, Romagnoli C, Kassam Z, Harle CC, Hafron J, Nandalur KR, Chronik BA, Burtnyk M, Schlemmer HP, Pahernik S.

Eur Urol. 2016 Sep;70(3):447-55. doi: 10.1016/j.eururo.2015.12.029. Epub 2016 Jan 6.

PMID:
26777228
24.

Comparative morbidity of ablative energy-based salvage treatments for radio-recurrent prostate cancer.

Siddiqui KM, Billia M, Williams A, Alzahrani A, Chin JL.

Can Urol Assoc J. 2015 Sep-Oct;9(9-10):325-9. doi: 10.5489/cuaj.3113.

25.

CUA-CUOG CRPC Guidelines: A useful compendium.

Chin JL.

Can Urol Assoc J. 2015 Mar-Apr;9(3-4):E224-5. doi: 10.5489/cuaj.2873. No abstract available.

26.

Extracellular vesicles such as prostate cancer cell fragments as a fluid biopsy for prostate cancer.

Brett SI, Kim Y, Biggs CN, Chin JL, Leong HS.

Prostate Cancer Prostatic Dis. 2015 Sep;18(3):213-20. doi: 10.1038/pcan.2015.17. Epub 2015 May 12. Review.

PMID:
25964141
27.

A Brief Survey of Active Surveillance.

Chin JL.

Eur Urol. 2015 Nov;68(5):812-3. doi: 10.1016/j.eururo.2015.04.005. Epub 2015 Apr 22. No abstract available.

PMID:
25913066
28.
29.

Ferritin in decompensated cirrhosis: iron or inflammation?

Ryan JD, Chin JL, Crowe J.

J Hepatol. 2015 Feb;62(2):499-500. doi: 10.1016/j.jhep.2014.08.058. Epub 2014 Nov 7. No abstract available.

30.

Reply: To PMID 25443920.

Yutkin V, Chin JL.

Urology. 2014 Nov;84(5):1162. doi: 10.1016/j.urology.2014.06.056. Epub 2014 Oct 24. No abstract available.

PMID:
25443922
31.

Salvage high-intensity focused ultrasound for patients with recurrent prostate cancer after brachytherapy.

Yutkin V, Ahmed HU, Donaldson I, McCartan N, Siddiqui K, Emberton M, Chin JL.

Urology. 2014 Nov;84(5):1157-62. doi: 10.1016/j.urology.2014.06.054. Epub 2014 Oct 24.

PMID:
25443920
32.

Thrombocytopenia, Platelet Transfusion, and Outcome Following Liver Transplantation.

Chin JL, Hisamuddin SH, O'Sullivan A, Chan G, McCormick PA.

Clin Appl Thromb Hemost. 2016 May;22(4):351-60. doi: 10.1177/1076029614559771. Epub 2014 Nov 26.

PMID:
25430936
33.

A prospective 52 week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy.

Hall B, Holleran G, Chin JL, Smith S, Ryan B, Mahmud N, McNamara D.

J Crohns Colitis. 2014 Dec;8(12):1601-9. doi: 10.1016/j.crohns.2014.09.005. Epub 2014 Sep 23.

PMID:
25257546
34.

Homozygosity for HLA group 2 alleles predicts treatment failure with interferon-α and ribavirin in chronic hepatitis C virus genotype 1 infection.

Collison M, Chin JL, Abu Shanab A, Mac Nicholas R, Segurado R, Coughlan S, Connell J, Carr MJ, Merriman RB, McCormick PA, Hall WW.

J Interferon Cytokine Res. 2015 Feb;35(2):126-33. doi: 10.1089/jir.2014.0088. Epub 2014 Sep 19.

PMID:
25237729
35.

Spleen stiffness can non-invasively assess resolution of portal hypertension after liver transplantation.

Chin JL, Chan G, Ryan JD, McCormick PA.

Liver Int. 2015 Feb;35(2):518-23. doi: 10.1111/liv.12647. Epub 2014 Aug 27.

PMID:
25074281
36.

Liver stiffness changes during meal times.

Chin JL, Farrelly A, Chan G, Norris S, McCormick PA.

Hepatology. 2014 Jul;60(1):432. doi: 10.1002/hep.26922. Epub 2014 May 27. No abstract available.

PMID:
24990107
37.

Three-year outcomes of recovery of erectile function after open radical prostatectomy with sural nerve grafting.

Siddiqui KM, Billia M, Mazzola CR, Alzahrani A, Brock GB, Scilley C, Chin JL.

J Sex Med. 2014 Aug;11(8):2119-24. doi: 10.1111/jsm.12600. Epub 2014 Jun 5.

PMID:
24903070
38.

Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.

Rodrigues G, Yao X, Loblaw DA, Brundage M, Chin JL.

Can Urol Assoc J. 2013 Nov;7(11-12):E783-7. Review. No abstract available.

39.

Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: results from a Canadian multicenter collaboration.

Bachir BG, Aprikian AG, Izawa JI, Chin JL, Fradet Y, Fairey A, Estey E, Jacobsen N, Rendon R, Cagiannos I, Lacombe L, Lattouf JB, Kapoor A, Matsumoto E, Saad F, Bell D, Black PC, So AI, Drachenberg D, Kassouf W.

Urol Oncol. 2014 May;32(4):441-8. doi: 10.1016/j.urolonc.2013.10.016. Epub 2014 Jan 10.

PMID:
24412632
40.

Women's health and behavioral health issues in health care reform.

Chin JL, Yee BW, Banks ME.

J Soc Work Disabil Rehabil. 2014;13(1-2):122-38. doi: 10.1080/1536710X.2013.870509.

PMID:
24410361
41.

Why is spleen stiffness better at predicting large esophageal varices and variceal bleeders?

Chin JL, Chan G, Ryan JD, McCormick PA.

Am J Gastroenterol. 2014 Jan;109(1):134. doi: 10.1038/ajg.2013.388. No abstract available.

PMID:
24402535
42.

3D prostate histology image reconstruction: Quantifying the impact of tissue deformation and histology section location.

Gibson E, Gaed M, Gómez JA, Moussa M, Pautler S, Chin JL, Crukley C, Bauman GS, Fenster A, Ward AD.

J Pathol Inform. 2013 Oct 31;4:31. doi: 10.4103/2153-3539.120874. eCollection 2013.

43.

Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.

Rodrigues G, Yao X, Loblaw DA, Brundage M, Chin JL.

Can Urol Assoc J. 2013 Nov;7(11-12):463-70. doi: 10.5489/cuaj.1482. Review.

44.

Regional differences in practice patterns and outcomes in patients treated with radical cystectomy in a universal healthcare system.

Bachir BG, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W.

Can Urol Assoc J. 2013 Nov-Dec;7(11-12):E667-72. doi: 10.5489/cuaj.201.

45.

Optimizing the management of pathologic, possible, and putative N1 prostate cancer.

Chin JL.

Eur Urol. 2014 Mar;65(3):563-4. doi: 10.1016/j.eururo.2013.10.010. Epub 2013 Oct 18. No abstract available.

PMID:
24269217
46.

Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression.

Palmer TD, Martínez CH, Vasquez C, Hebron KE, Jones-Paris C, Arnold SA, Chan SM, Chalasani V, Gomez-Lemus JA, Williams AK, Chin JL, Giannico GA, Ketova T, Lewis JD, Zijlstra A.

Cancer Res. 2014 Jan 1;74(1):173-87. doi: 10.1158/0008-5472.CAN-13-0275. Epub 2013 Nov 12.

47.

Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancer.

Yafi FA, Aprikian AG, Chin JL, Fradet Y, Izawa J, Estey E, Fairey A, Rendon R, Cagiannos I, Lacombe L, Lattouf JB, Saad F, Bell D, Drachenberg D, Kassouf W.

World J Urol. 2014 Oct;32(5):1295-301. doi: 10.1007/s00345-013-1207-z. Epub 2013 Nov 10.

PMID:
24213922
48.

Effects of portal hypertension on contractility of rat spleen.

Chin JL, Aiden McCormick P, Docherty JR.

Eur J Pharmacol. 2013 Dec 5;721(1-3):1-4. doi: 10.1016/j.ejphar.2013.09.063. Epub 2013 Oct 17.

PMID:
24140433
49.

3D prostate histology reconstruction: an evaluation of image-based and fiducial-based algorithms.

Gibson E, Gaed M, Gómez JA, Moussa M, Romagnoli C, Pautler S, Chin JL, Crukley C, Bauman GS, Fenster A, Ward AD.

Med Phys. 2013 Sep;40(9):093501. doi: 10.1118/1.4816946.

PMID:
24007184
50.

Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer.

Rodrigues G, Yao X, Loblaw DA, Brundage M, Chin JL; Genitourinary Cancer Disease Site Group.

Can Urol Assoc J. 2013 May-Jun;7(5-6):E411-6. doi: 10.5489/cuaj.478.

Supplemental Content

Support Center